Skip to main content
Erschienen in: Abdominal Radiology 6/2019

23.02.2019 | Hepatobiliary

Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018

verfasst von: Daniel R. Ludwig, Tyler J. Fraum, Roberto Cannella, David H. Ballard, Richard Tsai, Muhammad Naeem, Maverick LeBlanc, Amber Salter, Allan Tsung, Anup S. Shetty, Amir A. Borhani, Alessandro Furlan, Kathryn J. Fowler

Erschienen in: Abdominal Radiology | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The Liver Imaging Reporting and Data System (LI-RADS) was created to standardize the diagnostic criteria for hepatocellular carcinoma (HCC) and has undergone multiple revisions including a recent update in 2018 (v2018). The primary aim of this study was to determine the diagnostic performance and interrater reliability (IRR) of LI-RADS v2018 for distinguishing HCC from non-HCC primary hepatic malignancy in patients ‘at-risk’ for HCC. A secondary aim was to assess the impact of changes introduced in the v2018 diagnostic algorithm.

Methods

This retrospective study combined a 10-year experience of pathologically proven primary liver malignancies from two large liver transplant centers. Two blinded readers independently evaluated each lesion and assigned a LI-RADS diagnostic category, additionally scoring all relevant imaging features. Changes in category based on the reader-provided features and the new v2018 criteria were assessed by a study coordinator.

Results

The final study cohort comprised 105 HCCs and 73 non-HCC primarily liver malignancies. LI-RADS had a high specificity for distinguishing HCC from non-HCC (89% and 90% for reader 1 and reader 2, respectively), and IRR was moderate to substantial for final LI-RADS category and most features. Revision of the LI-RADS v2018 diagnostic algorithm resulted in very few changes [5 (2.8%) and 3 (1.7%) for reader 1 and reader 2, respectively] in overall lesion classification.

Conclusion

LI-RADS diagnostic categories and features had moderate to substantial IRR and high specificity for distinguishing HCC from non-HCC primary liver malignancy. Revision of LI-RADS v2018 diagnostic algorithm resulted in reclassification of very few lesions.
Literatur
2.
Zurück zum Zitat Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-700.CrossRefPubMed Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334:693-700.CrossRefPubMed
3.
Zurück zum Zitat Roberts LR, Sirlin CB, Zaiem F, Almasri J, Prokop LJ, Heimbach JK, et al (2018) Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis. Hepatology 67:401-21.CrossRefPubMed Roberts LR, Sirlin CB, Zaiem F, Almasri J, Prokop LJ, Heimbach JK, et al (2018) Imaging for the diagnosis of hepatocellular carcinoma: A systematic review and meta‐analysis. Hepatology 67:401-21.CrossRefPubMed
4.
Zurück zum Zitat Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J (2013) New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 266:376-82.CrossRefPubMed Wald C, Russo MW, Heimbach JK, Hussain HK, Pomfret EA, Bruix J (2013) New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology 266:376-82.CrossRefPubMed
5.
Zurück zum Zitat Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions. Hepatology 61:1056-65.CrossRefPubMed Mitchell DG, Bruix J, Sherman M, Sirlin CB (2015) LI‐RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI‐RADS Management Working Group and future directions. Hepatology 61:1056-65.CrossRefPubMed
6.
Zurück zum Zitat Fraum TJ, Tsai R, Rohe E, Ludwig DR, Salter A, Nalbantoglu I, et al (2017) Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the liver imaging reporting and data system version 2014. Radiology 286:158-72.CrossRefPubMed Fraum TJ, Tsai R, Rohe E, Ludwig DR, Salter A, Nalbantoglu I, et al (2017) Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the liver imaging reporting and data system version 2014. Radiology 286:158-72.CrossRefPubMed
7.
Zurück zum Zitat Elsayes KM, Hooker JC, Agrons MM, Kielar AZ, Tang A, Fowler KJ, et al (2017) 2017 version of LI-RADS for CT and MR imaging: an update. Radiographics 37:1994-2017.CrossRefPubMed Elsayes KM, Hooker JC, Agrons MM, Kielar AZ, Tang A, Fowler KJ, et al (2017) 2017 version of LI-RADS for CT and MR imaging: an update. Radiographics 37:1994-2017.CrossRefPubMed
8.
Zurück zum Zitat Vilchez V, Shah MB, Daily MF, Pena L, Tzeng CW, Davenport D, et al (2016) Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database. HPB (Oxford) 18:29-34.CrossRef Vilchez V, Shah MB, Daily MF, Pena L, Tzeng CW, Davenport D, et al (2016) Long-term outcome of patients undergoing liver transplantation for mixed hepatocellular carcinoma and cholangiocarcinoma: an analysis of the UNOS database. HPB (Oxford) 18:29-34.CrossRef
9.
Zurück zum Zitat Sapisochin G, Fidelman N, Roberts JP, Yao FY (2011) Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl 17:934-42.CrossRefPubMed Sapisochin G, Fidelman N, Roberts JP, Yao FY (2011) Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma. Liver Transpl 17:934-42.CrossRefPubMed
10.
Zurück zum Zitat Joo I, Lee JM, Lee SM, Lee JS, Park JY, Han JK (2016) Diagnostic accuracy of liver imaging reporting and data system (LI‐RADS) v2014 for intrahepatic mass‐forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid‐enhanced MRI. J Magn Reson Imaging 44:1330-8.CrossRefPubMed Joo I, Lee JM, Lee SM, Lee JS, Park JY, Han JK (2016) Diagnostic accuracy of liver imaging reporting and data system (LI‐RADS) v2014 for intrahepatic mass‐forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid‐enhanced MRI. J Magn Reson Imaging 44:1330-8.CrossRefPubMed
11.
Zurück zum Zitat Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, Fujita N, et al (2015) Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI. Diagn Interv Radiol. 21:96.CrossRefPubMedPubMedCentral Asayama Y, Nishie A, Ishigami K, Ushijima Y, Takayama Y, Fujita N, et al (2015) Distinguishing intrahepatic cholangiocarcinoma from poorly differentiated hepatocellular carcinoma using precontrast and gadoxetic acid-enhanced MRI. Diagn Interv Radiol. 21:96.CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Park HJ, Jang KM, Kang TW, Song KD, Kim SH, Kim YK, et al (2016) Identification of imaging predictors discriminating different primary liver tumours in patients with chronic liver disease on gadoxetic acid-enhanced MRI: a classification tree analysis. Eur Radiol 26:3102-11.CrossRefPubMed Park HJ, Jang KM, Kang TW, Song KD, Kim SH, Kim YK, et al (2016) Identification of imaging predictors discriminating different primary liver tumours in patients with chronic liver disease on gadoxetic acid-enhanced MRI: a classification tree analysis. Eur Radiol 26:3102-11.CrossRefPubMed
13.
Zurück zum Zitat Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma (2018) Abdom Radiol (NY) 43:149-57.CrossRef Fowler KJ, Potretzke TA, Hope TA, Costa EA, Wilson SR. LI-RADS M (LR-M): definite or probable malignancy, not specific for hepatocellular carcinoma (2018) Abdom Radiol (NY) 43:149-57.CrossRef
14.
Zurück zum Zitat Xu J, Igarashi S, Sasaki M, Matsubara T, Yoneda N, Kozaka K, et al (2012) Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int 32:1156-64.CrossRefPubMed Xu J, Igarashi S, Sasaki M, Matsubara T, Yoneda N, Kozaka K, et al (2012) Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int 32:1156-64.CrossRefPubMed
15.
Zurück zum Zitat Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumours of the digestive system. Lyon, France: IARC Press. Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumours of the digestive system. Lyon, France: IARC Press.
16.
Zurück zum Zitat Brunt E, Aishima S, Clavien PA, Fowler K, Goodman Z, Gores G, et al (2018) cHCC‐CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. Hepatology 68:113-126.CrossRefPubMedPubMedCentral Brunt E, Aishima S, Clavien PA, Fowler K, Goodman Z, Gores G, et al (2018) cHCC‐CCA: Consensus terminology for primary liver carcinomas with both hepatocytic and cholangiocytic differentation. Hepatology 68:113-126.CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Magistri P, Tarantino G, Serra V, Guidetti C, Ballarin R, Di Benedetto F (2017) Liver transplantation and combined hepatocellular-cholangiocarcinoma: Feasibility and outcomes. Dig Liver Dis 49:467-70.CrossRefPubMed Magistri P, Tarantino G, Serra V, Guidetti C, Ballarin R, Di Benedetto F (2017) Liver transplantation and combined hepatocellular-cholangiocarcinoma: Feasibility and outcomes. Dig Liver Dis 49:467-70.CrossRefPubMed
18.
Zurück zum Zitat Furlan A, Almusa O, Yu RK, Sagreiya H, Borhani AA, Bae KT, Marsh JW (2018) A radiogenomic analysis of hepatocellular carcinoma: association between fractional allelic imbalance rate index and the liver imaging reporting and data system (LI-RADS) categories and features. Br J Radiol 91:1086. Furlan A, Almusa O, Yu RK, Sagreiya H, Borhani AA, Bae KT, Marsh JW (2018) A radiogenomic analysis of hepatocellular carcinoma: association between fractional allelic imbalance rate index and the liver imaging reporting and data system (LI-RADS) categories and features. Br J Radiol 91:1086.
19.
22.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159-74.CrossRef Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159-74.CrossRef
23.
Zurück zum Zitat Mercaldo ND, Lau KF, Zhou XH (2007) Confidence intervals for predictive values with an emphasis to case–control studies. Stat Med 26:2170-83.CrossRefPubMed Mercaldo ND, Lau KF, Zhou XH (2007) Confidence intervals for predictive values with an emphasis to case–control studies. Stat Med 26:2170-83.CrossRefPubMed
24.
Zurück zum Zitat Benjamini Y, Yekutieli D (2001) The control of the false discovery rate in multiple testing under dependency. Ann Statist 29:1165-88.CrossRef Benjamini Y, Yekutieli D (2001) The control of the false discovery rate in multiple testing under dependency. Ann Statist 29:1165-88.CrossRef
25.
Zurück zum Zitat Bergquist JR, Groeschl RT, Ivanics T, Shubert CR, Habermann EB, Kendrick ML, et al (2016) Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics. HPB (Oxford) 18:886-92.CrossRef Bergquist JR, Groeschl RT, Ivanics T, Shubert CR, Habermann EB, Kendrick ML, et al (2016) Mixed hepatocellular and cholangiocarcinoma: a rare tumor with a mix of parent phenotypic characteristics. HPB (Oxford) 18:886-92.CrossRef
26.
Zurück zum Zitat Fowler KJ, Sheybani A, Parker RA III, Doherty S, M Brunt E, Chapman WC, et al (2013) Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR Am J Roentgenol 201:332-9.CrossRefPubMed Fowler KJ, Sheybani A, Parker RA III, Doherty S, M Brunt E, Chapman WC, et al (2013) Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI. AJR Am J Roentgenol 201:332-9.CrossRefPubMed
27.
Zurück zum Zitat Jeon SK, Joo I, Lee DH, Lee SM, Kang HJ, Lee KB, et al (2018) Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging. Eur Radiology. https://doi.org/10.1007/s00330-018-5605-x. Jeon SK, Joo I, Lee DH, Lee SM, Kang HJ, Lee KB, et al (2018) Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging. Eur Radiology. https://​doi.​org/​10.​1007/​s00330-018-5605-x.
28.
Zurück zum Zitat Fowler KJ, Tang A, Santillan C, Bhargavan-Chatfield M, Heiken J, Jha RC, et al (2018) Interreader Reliability of LI-RADS version 2014 algorithm and imaging features for diagnosis of hepatocellular carcinoma: a large international multireader study. Radiology 286:173-85.CrossRefPubMed Fowler KJ, Tang A, Santillan C, Bhargavan-Chatfield M, Heiken J, Jha RC, et al (2018) Interreader Reliability of LI-RADS version 2014 algorithm and imaging features for diagnosis of hepatocellular carcinoma: a large international multireader study. Radiology 286:173-85.CrossRefPubMed
29.
Zurück zum Zitat Ehman EC, Behr SC, Umetsu SE, Fidelman N, Yeh BM, Ferrell LD, et al (2016) Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol (NY) 41:963-9.CrossRefPubMedCentral Ehman EC, Behr SC, Umetsu SE, Fidelman N, Yeh BM, Ferrell LD, et al (2016) Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol (NY) 41:963-9.CrossRefPubMedCentral
30.
Zurück zum Zitat Davenport MS, Khalatbari S, Liu PS, Maturen KE, Kaza RK, Wasnik AP, et al (2014) Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology 272:132-42.CrossRefPubMedPubMedCentral Davenport MS, Khalatbari S, Liu PS, Maturen KE, Kaza RK, Wasnik AP, et al (2014) Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging. Radiology 272:132-42.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Becker AS, Barth BK, Marquez PH, Donati OF, Ulbrich EJ, Karlo C, et al (2017) Increased interreader agreement in diagnosis of hepatocellular carcinoma using an adapted LI-RADS algorithm. Eur J Radiol 86:33-40.CrossRefPubMed Becker AS, Barth BK, Marquez PH, Donati OF, Ulbrich EJ, Karlo C, et al (2017) Increased interreader agreement in diagnosis of hepatocellular carcinoma using an adapted LI-RADS algorithm. Eur J Radiol 86:33-40.CrossRefPubMed
32.
Zurück zum Zitat Horowitz JM, Venkatesh SK, Ehman RL, Jhaveri K, Kamath P, Ohliger MA, et al (2017) Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY) 42:2037-53.CrossRef Horowitz JM, Venkatesh SK, Ehman RL, Jhaveri K, Kamath P, Ohliger MA, et al (2017) Evaluation of hepatic fibrosis: a review from the society of abdominal radiology disease focus panel. Abdom Radiol (NY) 42:2037-53.CrossRef
33.
Zurück zum Zitat Kudo M, Zheng RQ, Kim SR, Okabe Y, Osaki Y, Iijima H, et al (2008) Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. Intervirology 51:17-26.CrossRefPubMed Kudo M, Zheng RQ, Kim SR, Okabe Y, Osaki Y, Iijima H, et al (2008) Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. Intervirology 51:17-26.CrossRefPubMed
34.
Zurück zum Zitat Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358-80.CrossRefPubMed Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, et al (2018) AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 67:358-80.CrossRefPubMed
35.
Zurück zum Zitat Venkatesh SK, Yin M, Ehman RL (2013) Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging 37:544-55.CrossRefPubMedPubMedCentral Venkatesh SK, Yin M, Ehman RL (2013) Magnetic resonance elastography of liver: technique, analysis, and clinical applications. J Magn Reson Imaging 37:544-55.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 43:1317-25.CrossRefPubMed Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 43:1317-25.CrossRefPubMed
Metadaten
Titel
Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of Liver Imaging Reporting and Data System v2018
verfasst von
Daniel R. Ludwig
Tyler J. Fraum
Roberto Cannella
David H. Ballard
Richard Tsai
Muhammad Naeem
Maverick LeBlanc
Amber Salter
Allan Tsung
Anup S. Shetty
Amir A. Borhani
Alessandro Furlan
Kathryn J. Fowler
Publikationsdatum
23.02.2019
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 6/2019
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-019-01948-x

Weitere Artikel der Ausgabe 6/2019

Abdominal Radiology 6/2019 Zur Ausgabe

Classics in Abdominal Radiology

The “kissing sign” of liver and spleen

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.